Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-08

FDA Approved: LOTRONEX — Supplemental Application (Legacy Pharma USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lotronex (alosetron hydrochloride) from Legacy Pharma USA Inc., indicating an approval-related action for this produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOTRONEX (alosetron hydrochloride)

Snippet

SUPPL AP for LOTRONEX (ALOSETRON HYDROCHLORIDE)